Orexo AB (ORX) Rise 1.25% on Dec 7

December 7, 2017 - By Richard Conner

Shares of Orexo AB (STO:publ) last traded at 40.6, representing a move of 1.25%, or 0.5 per share, on volume of 25,591 shares. After opening the trading day at 40.1, shares of Orexo AB traded in a close

range. Orexo AB currently has a total float of 34.54 million shares and on average sees 198,355 shares exchange hands each day. The stock now has a 52-week low of 26 and high of 52.75.

The OMX Stockholm 30 Index: Driving Sweden Economy

The OMX Stockholm 30 Index, or OMXS30, is the stock index for the 30 largest and actively traded companies on the Stockholm Stock Exchange, better known as Nasdaq Stockholm. Orexo AB is also represented at the market. The index is market capitalization-weighted and it is reshuffled twice a year where components that fall short of listing requirements are dropped and newly qualified stocks added. Dropped stocks can be readmitted to the index if they meet the requirements in the next rebalancing.

OMXS30 is adjusted to reflect changes in the market cap of its components. Such changes can result from companies issuing new stock to raise capital or convertible notes converting to stock if such transactions affect the market capitalization of the component.

OMXS30 was developed with a base value of 125 points in September 1986. The index went on to plunge to a record low of 98.86 points in November 1987, with the decline was linked to Black Monday rout that saw many stock markets shed huge value over a short time. Stock markets began crashing in Hong Kong on October 19, 1987 and spread quickly to Europe to the U.S. However, OMXS30 gradually recovered from the trough and hit its all-time high of 1719.93 points in April 2015.

OMXS30 is a key benchmark index for Stockholm stocks. Orexo AB stocks is trusted enough to be in OMXS30. Components of the index represent various industries. Financials, Industrials and Consumer services are the largest sectors in OMXS30.

Nasdaq Stockholm

Nasdaq Stockholm, Sweden’s primary stock exchange, lists more than 300 companies. The stock market was established 1863, but has changed names multiple times, including after the merge between futures exchange OM and Stockholm Stock Exchange.

Electronic trading on Nasdaq Stockholm was introduced in June 1990. Before the electronic trading was enabled on the exchange, all trading took place on the floor of the Stockholm Stock Exchange Building floor.

Trading on Nasdaq Stockholm begins at 9.00 a.m. and runs through 5.30 p.m. every weekday. Orexo AB leads its operations until the last hour. The market is closed on weekends and holidays announced by the exchange.

Excitement in Stockholm stocks

Nasdaq Stockholm has been active in recent years as lower interest rates in the Eurozone fuel stock investment. The lower costs of credit in the Eurozone are part of economic stimulus measures that have helped lift consumer purchase power, especially backing growth and profitability in consumer products companies. The European Central Bank has also stepped up its bond buying to increase the supply of cash in the region’s economy.

Sweden is particularly reaping the benefits of the cheap money in Europe because of its vibrant Financials sector. That is partly Swedish stocks are seeing an influx of investors from domestically, the Europe region and beyond. Investors are further attracted by glowing growth prospects of companies in the country as cheap money due to low interest rates drives uptake of industrial equipment. A booming services and manufacturing industries and strong corporate governance standards are some of the reasons retail investors are buying up Swedish stocks. Stocks Orexo AB are in the main sphere of interest for some investors.

Investor drift to Sweden in the recent months can also be linked to expectations that the country will reap from Brexit crisis as some financial services providers relocate from London.

More notable recent Orexo AB (STO:publ) news were published by: Prnewswire.com which released: “Report From Orexo AB´s Annual General Meeting, April 6 2017” on April 06, 2017, also Marketwatch.com with their article: “Orexo AB ADR” published on November 20, 2013, Businesswire.com published: “Mundipharma and Orexo Announce EU Regulatory Submission for Zubsolv®” on October 04, 2016. More interesting news about Orexo AB (STO:publ) were released by: Businesswire.com and their article: “Orexo: US FDA Approves ZUBSOLV® for Induction of Buprenorphine Maintenance …” published on August 11, 2015 as well as Businesswire.com‘s news article titled: “Orexo Settles Abstral® US Patent Litigation with Actavis” with publication date: October 27, 2015.

Orexo AB , a specialty pharmaceutical company, engages in the development and commercialization of drugs in the United States. The company has market cap of $1.41 billion. The companyÂ’s product portfolio comprises launched products, proprietary development programs, and collaboration projects. It has a 74.09 P/E ratio. The Company’s launched products include Zubsolv sublingual tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, an active substance zolpidem that is used for the treatment of short-term insomnia.


Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.